PillRx only · Capsule, Extended Release · Oral
Morphine Sulfate
Morphine Sulfate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US26 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers4 labelers
Packages45
DEA / ScheduleCII
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.493
Latest avg · Jun 17, 2026
+6%
Since Mar 19, 2025
4
Active US suppliers
73%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | unknown | 19 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 14 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 6 | SUPPLYING |
| Nortec Development Associates, Inc. | unknown | 6 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.